Loading stock data…
Health In Tech, Inc. (HIT)
$1.01-0.03 (-2.88%)
Market ClosedLast close Jun 29
Health In Tech, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Health In Tech, Inc. in the Technology sector is trading at $1.01 with a market capitalization of $63M. Wall Street consensus targets $4.03 (3 analysts), implying a +299.3% move over the next 12 months. The stock is currently near its 52-week low of $0.81, remaining 42.0% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +299.3% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $8.77M↑ | $7.51M↓ | $8.49M↓ | $9.31M↑ | $8.01M |
| Gross Profit | $4.51M↑ | $4.13M↓ | $5.14M↓ | $6.31M↑ | $5.36M |
| Operating Income | -$2.16M↓ | -$170,813↓ | $493,523↓ | $725,070↑ | $480,658 |
| Net Income | -$1.59M↓ | -$302,557↓ | $452,176↓ | $630,631↑ | $498,592 |
Peer Comparison
AAPLMSFTGOOGL
Fundamentals
Health In Tech, Inc. operates as an insurance technology platform company in the United States. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; SMR, a...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$63.25M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-3.74%
Volume
Today's trading volume
99,844
Recent News
Health In Tech Q1 Earnings Call Highlights
Health In Tech (NASDAQ:HIT) reported first-quarter 2026 revenue growth and a wider loss as management said the company is intentionally increasing investment in sales distribution, carrier relationships and technology development to pursue a larger share of the self-funded health insurance market.
Health In Tech Q1 2026 Earnings Call: Complete Transcript
Health In Tech (NASDAQ:HIT) held its first-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/apis/ for a consultation. View the webcast at https://event.choruscall.com/mediaframe/webcast.html?webcastid=Bt2YoZ7W Summary Health In Tech reported Q1 2026 revenue of $8.8 million, a 9% year-over-year growth, with expectations
Health In Tech HIT Q2 2025 Earnings Transcript
Joining us today are Mr. Tim Johnson, Chief Executive Officer, Mr. Dustin Plantholt, Chief Growth Officer, and Ms. Julia Chen, Chief Financial Officer. With that, I now turn the call over to our CEO, Mr. Tim Johnson.
Is Now The Time To Put Health In Tech (NASDAQ:HIT) On Your Watchlist?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Health In Tech, Inc. Q4 2025 Earnings Call Summary
Moby summary of Health In Tech, Inc.'s Q4 2025 earnings call